Skip to Main Content

Paper Details

Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
J Infect Dis
7
2020
Author NameAffiliation
Mark S SulkowskiJohns Hopkins University School of Medicine
Laura SmeatonHarvard T.H. Chan School of Public Health
  • 1 - 2

Datasets